About The Course
Transcranial Magnetic Stimulation for Depression is an evidence-based neuromodulation course presented by Professor David Barton. Explore the mechanisms, protocols, and clinical integration of TMS in complex cases, including treatment-resistant depression and TMS. This course provides practical insights for psychiatrists, general practitioners and mental health professionals seeking to enhance therapeutic outcomes through advanced neurostimulation techniques.
Who Is This Course For?
This course is suitable for:
- Psychiatrists
- General Practitioners (GPs)
- Mental Health Nurse Practitioners (MHNPs)
- Psychologists
- Mental health professionals
- Clinicians working in or expanding into psychiatry and mental health care
Accreditation Information:
- Psychiatry Accreditation: This course is available for self-accreditation with the RANZCP and other relevant psychiatric and mental health organisations.
- GP Accreditation: This course is available for self-accreditation with RACGP for general practitioners.
What You'll Learn
- The evidence for the benefits of TMS in the management of major depression
- When is it appropriate to introduce TMS in the management pathway?
- How to introduce your patient to TMS as a therapy?
- Maintenance therapy post-treatment with TMS?
Course Programme
6 Units | 17 Modules | 1.5 Hours total length
- Fundamentals and Neurobiology
- Historical Development and Current Landscape
- Equipment, Setup, and Resting Motor Threshold (RMT) Determination
- Stimulation Protocols and Hemisphere Targeting
- Safety, Side Effects, and Contraindications
- Patient Selection and Treatment Resistance
- Comparative and Combination Therapies (Ketamine, ECT)
- Maintenance and Long-Term Management
- Depression, Anxiety, PTSD, and OCD Symptom Domains
- Schizophrenia and Bipolar Disorder Applications
- ADHD and Neurodevelopmental Disorders
- Cognitive Disorders and Neurological Conditions
- Research Advances and Clinical Trials
- Training and Education Needs in Psychiatry
- Patient Consultation and Education
- Funding, Access, and Health Economics
- Equipment Logistics and Service Delivery
Course Description
Transcranial Magnetic Stimulation for Depression: Clinical Application and Emerging Insights
Overview and Course Relevance
Transcranial Magnetic Stimulation for Depression is shaping a new frontier in psychiatric care, offering a safe, effective neuromodulation approach for complex cases. In this on-demand course, Professor David Barton delivers clinically grounded insights into TMS, illustrating its role in modern psychiatric practice. Through real-world examples and practical strategies, the course empowers clinicians to implement advanced neurostimulation confidently. Tailored for psychiatrists, general practitioners, and mental health professionals, the content blends scientific depth with clinical relevance.
Foundations, Mechanisms, and Technical Protocols
The course opens with key TMS principles, tracing its evolution from early neurostimulation research to current evidence-based use. Professor Barton outlines the neurobiological rationale behind TMS, explaining how cortical targeting, frequency, and hemisphere selection influence excitatory or inhibitory outcomes. He details essential procedures such as determining the resting motor threshold (RMT) and optimising session timing, offering a practical guide to TMS protocols in clinical psychiatry.
Clinical Integration in Depression and Psychiatric Comorbidities
Building on foundational knowledge, the course examines Transcranial Magnetic Stimulation for depression in complex clinical scenarios. Professor Barton focuses on treatment-resistant depression and TMS, outlining when to continue pharmacotherapy and when to consider combining TMS with esketamine or ECT. He discusses applications across PTSD, OCD, bipolar disorder, and schizophrenia, demonstrating TMS’s versatility in addressing comorbidities and improving domains such as suicidality and cognitive dysfunction.
Future Directions and Practical Considerations
The final modules explore emerging evidence for TMS in cognitive and neurodevelopmental conditions, including ADHD and autism spectrum presentations. While some protocols remain under development, current research signals promising clinical applications. Professor Barton also addresses operational issues—such as safety, side effect management, and functional outcomes—giving clinicians a realistic perspective on integrating TMS into practice.
What You Will Learn
By the end of this course, participants will be able to:
- Understand the evidence for Transcranial Magnetic Stimulation for Depression
- Identify when to introduce TMS in the treatment pathway
- Communicate effectively with patients about TMS as a therapeutic option
- Apply strategies for maintenance therapy following TMS
Advance your clinical expertise in neuromodulation—enrol now and learn how TMS can transform treatment pathways for complex psychiatric presentations.
While our Academy members enjoy exclusive access to a range of courses and webinars (including this course) with their annual membership, we’re pleased to offer you the opportunity to purchase it individually! Click here – Transcranial Magnetic Stimulation (TMS): Evidence and Practical Application.
‘Transcranial Magnetic Stimulation (TMS): Evidence and Practical Application’ with Professor David Barton is available in both video and audio format. Participants will receive a completion certificate and 1.5 CPD hours upon completion.
Learn how TMS protocols in clinical psychiatry are applied in treatment-resistant depression. Gain practical insights into the safe and effective use of TMS across a range of psychiatric conditions.
Course Information
- 1.5 hours
- 1.5 CPD
Inclusions
- 1.5 Hours of Video Lecture
- Course Completion Certificate
Material Downloads
- certificate
Instructors
Professor David Barton Guest Speaker - MBBS FRANZCP PhD
Prof David Barton is the founding director of NeuroCentrix, providing care focused on treatment-resistant depression, brain injury and early dementia. For treatment-resistant depression, he offers TMS and Esketamine treatment in Victoria, Queensland and Tasmania. David’s subspecialty is in old-age psychiatry, neuropsychiatry(acquired brain injury) and treatment-resistant mood disorders. He has an extensive background in academia with research areas into ketamine, depression and cardiovascular disease funded through NHMRC grants.
Prof Barton’s other roles include: Director of mental health services at South Eastern Private Hospital, Consultation Liaison Psychiatrist with the Acquired Brain Injury Unit at Caulfield Hospital, Adjunct Professor at the Australian Centre for Heart Health, Senior Research Scientist at the BakerIDI Heart and Diabetes Institute’s Human Neurotransmitter Laboratory, and Honorary Principal Fellow at the University of Melbourne.
Dr. Sanil Rege Host - MBBS, MRCPsych, FRANZCP
With extensive teaching experience through psychiatry education initiatives, Sanil is recognized as a motivational training facilitator and educator who promotes insightful collaboration and discussion
As the Academic Lead of Psych Scene and Chief Editor of Psych Scene Hub, he aspires to make a difference in mental health by empowering Healthcare Professionals to advance their skills and career through the provision of specialised education and training
Sanil is also the founder of Vita Healthcare, a private clinic in Mount Eliza specialising in adult mental healthcare, with over 20 years of clinical experience and 13 years of private practice experience treating disorders across the spectrum. He currently works in the community, across inpatient, consultation-liaison and addiction psychiatry spaces.
